Neutrophil-to-Eosinophil Ratio Predicts the Efficacy of Avelumab in Patients With Advanced Urothelial Carcinoma Enrolled in the MALVA Study (Meet-URO 25)
2024 · Clinical Genitourinary Cancer · 9 citations
https://doi.org/10.1016/j.clgc.2024.102099
I
Irene De Gennaro Aquino
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
12
Papers
23
Citations
2
h-index
1
i10-index
Irene De Gennaro Aquino is an academic researcher from Azienda Ospedaliero-Universitaria Careggi. The author has contributed to research in topics: Bladder and Urothelial Cancer Treatments & Cancer Immunotherapy and Biomarkers & Urinary and Genital Oncology Studies. The author has an h-index of 2, co-authored 11 publications.
Papers by this author
worksCorrelation Between Tumor Response and Survival Outcomes in Patients with Advanced Gastric Cancer Receiving Ramucirumab and Paclitaxel as Second-Line Therapy
2022 · Journal of Gastrointestinal Cancer · 1 citations
https://doi.org/10.1007/s12029-022-00865-5
Overlapping Extremes: An Analysis of Avelumab Maintenance and Pembrolizumab in Advanced Urothelial Carcinoma
2025 · Oncology and Therapy · 0 citations
https://doi.org/10.1007/s40487-025-00387-7
Impact of adverse events on survival outcomes in patients treated with CDK4/6 inhibitors for advanced breast cancer
2025 · Cancer Chemotherapy and Pharmacology · 0 citations
https://doi.org/10.1007/s00280-025-04836-y
Site and number of metastases predict outcomes in avelumab maintenance for advanced UC: results from meet-URO 25
2026 · Cancer Immunology Immunotherapy · 0 citations
https://doi.org/10.1007/s00262-025-04270-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat